TREATMENT OF OBESITY AND OTHER DISORDERS ASSOCIATED WITH EXCESSIVE FOOD INTAKE
摘要
Modulators of metabotropic glutamate receptor-5 (mGluR5) are useful in treating disorders associated with excessive food intake, including obesity and obesity-related disorders. In particular, mGluR5 antagonists of structural formulae IA-IF are useful in treating these conditions, either as single agents or in combination with other compounds useful for treating obesity.
申请公布号
WO2004030637(A3)
申请公布日期
2004.09.23
申请号
WO2003US09717
申请日期
2003.03.31
申请人
MERCK & CO., INC.;BRADBURY, MARGARET, J.;COSFORD, NICHOLAS, D. P.;VARNEY, MARK, A.;ANDERSON, JEFFERY, J.
发明人
BRADBURY, MARGARET, J.;COSFORD, NICHOLAS, D. P.;VARNEY, MARK, A.;ANDERSON, JEFFERY, J.
